STAT

Opinion: Large insurers, payers commit to support evidence-based medical therapy for addiction

The largest medical payers in the U.S. have committed to promote and reward evidence-based medical therapy for treating addictions.

A bond forged in the kind of tragic personal loss that has become all too common in the United States — each of us had a son die from an addiction — compelled us to do something about the sorry state of addiction treatment today. That work is paying off, as many of the nation’s largest medical payers have just agreed to help close the shameful gap in treating addictions.

Drug overdoses are rising sharply,

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.

Related Books & Audiobooks